新安鼻渊方治疗鼻窦炎87例

Clinical Efficacy of Xinan Biyuan Fang in Treatment of Nasosinusitis:A Report of 87 Cases

目的观察新安鼻渊方治疗鼻窦炎的临床疗效。方法将115例鼻窦炎患者分为治疗组(87例)和对照组(28例)。治疗组患者口服新安鼻渊方,对照组患者服用藿胆丸。14d后观察并比较两组症状总积分及两组临床疗效。结果两组治疗后症状总积分均较治疗前显著降低(P<0.01),但治疗组症状总积分下降值显著大于对照组(P<0.01)。治疗组的肺经蕴热证疗效、胆腑郁热证疗效及其总体临床疗效均显著优于对照组(P<0.01)。结论新安鼻渊方对胆腑郁热和肺经蕴热型鼻窦炎具有较好的临床疗效。

Objective To observe the nasosinusitis. Methods A total of 11 clinical efficacy of Xin＇an Biyuan Fang （XABYF） in the treatment of 5 patients with nasosinusitis were divided into treatment group （n= 87） and control group （n=28）. The treatment group was orally given XABYF, while the control group received Huodan pills. After 14 d of treatment, the total symptom score and clinical outcome were compared between the two groups. Results After treatment, both groups showed significant decreases in total symptom score （p〈0.01）, and the treatment group had a significantly higher decrease （P〈0.01）. Compared with the control group, the treatment group had significantly more improvements in accumulated heat in lung meridian and stagnated heat of gallbladder and a significantly better overall clinical outcome （P〈0.01）. Conclusion XABYF has good clinical efficacy in nasosinusitis patients with stagnated heat of gallbladder and accumulated heat in lung meridian.